Cover Image

PAPERBACK
$63.25



View/Hide Left Panel

REFERENCES

Briggs AH, O’Brien BJ, Blackhouse G. 2002. Thinking outside the box: Recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health 23:377–401.


Chu KC, Tarone RE, Chow WH, Hankey BF, Ries L. 1994. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst 86(13):997–1006.

Cooper GS, Yuan Z, Landefeld CS, Johanson JF, Rimm AA. 1995. A national population-based study of incidence of colorectal cancer and age: Implications for screening in older Americans. Cancer. 75(3):775–781.

Cotton PB, Durkalski VL, Pineau BC, Palesch YY, Mauldin PD, Hoffman B, Vining DJ, Small WC, Affronti J, Rex D, Kopecky KK, Ackerman S, Burdick JS, Brewington C, Turner MA, Zfass A, Wright AR, Iyer RB, Lynch P, Sivak MV, Butler H. 2004. Computed tomographic colonography (virtual colonoscopy): A multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 291(14):1713–1719.

Curry S, Byers T, Hewitt M (eds). 2003. Fulfilling the Potential of Cancer Prevention and Early Detection. National Cancer Policy Board Institute of Medicine. Washington DC: The National Acadamies Press.


Devesa SS, Chow WH. 1993. Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 71(12):3819–3826.


Eddy DM. 1980. Screening for Cancer: Theory, Analysis and Design. Englewood Cliffs, NJ: Prentice-Hall.

Eddy DM, Nugent FW, Eddy JF, Coller J, Gilbertsen V, Gottlieb LS, Rice R, Sherlock P, Winawer S. 1987. Screening for colorectal cancer in a high-risk population. Results of a mathematical model. Gastroenterol 92(3):682–692.

Edwards BK, Howe HL, Ries LAG, Thun MJ, Rosenberg HM, Yancik R, Wingo PA, Jemal A, Feigal EG. 2002. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer 94(10):2766–2792.


Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. 2000. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 84(15):1954–1961.


Glick S, Wagner JL, Johnson CD. 1998. Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer. AJR AM JRoentgeno 170(3):629–636.

Gohagan JK, Prorok PC, Kramer BS, Hayes RB, Cornett JE. 1995. The prostate, lung, colorectal, and ovarian cancer screening trial of the National Cancer Institute. Cancer 75(7 Suppl.): 1869–1873.

Gold MR, Siegel J, Russell L, Weinstein, M. 1996. Cost-Effectiveness in Health and Medicine New York: Oxford University Press.


Herdman R, Norton L (eds). 2005. Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis. National Cancer Policy Board, Institute of Medicine. Washington DC: The National Acadamies Press.


Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. 2003. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med 139(12):959–965.


Jorgensen OD, Kronborg O, Fenger C. 2002. A randomised study of screening for colorectal cancer using faecal occult blood testing: Results after 13 years and seven biennial screening rounds. Gu. 50(1):29–32.

Joseph AM, Crowson TW, Rich EC. 1988. Cost effectiveness of HemoQuant versus Hemoccult for colorectal cancer screening. J Gen Intern Med 3(2):132–138.


Khandker RK, Dulski JD, Kilpatrick JB, Ellis RP, Mitchell JB, Baine WB. 2000. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care 16(3):799–810.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 31
Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary REFERENCES Briggs AH, O’Brien BJ, Blackhouse G. 2002. Thinking outside the box: Recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health 23:377–401. Chu KC, Tarone RE, Chow WH, Hankey BF, Ries L. 1994. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst 86(13):997–1006. Cooper GS, Yuan Z, Landefeld CS, Johanson JF, Rimm AA. 1995. A national population-based study of incidence of colorectal cancer and age: Implications for screening in older Americans. Cancer. 75(3):775–781. Cotton PB, Durkalski VL, Pineau BC, Palesch YY, Mauldin PD, Hoffman B, Vining DJ, Small WC, Affronti J, Rex D, Kopecky KK, Ackerman S, Burdick JS, Brewington C, Turner MA, Zfass A, Wright AR, Iyer RB, Lynch P, Sivak MV, Butler H. 2004. Computed tomographic colonography (virtual colonoscopy): A multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 291(14):1713–1719. Curry S, Byers T, Hewitt M (eds). 2003. Fulfilling the Potential of Cancer Prevention and Early Detection. National Cancer Policy Board Institute of Medicine. Washington DC: The National Acadamies Press. Devesa SS, Chow WH. 1993. Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 71(12):3819–3826. Eddy DM. 1980. Screening for Cancer: Theory, Analysis and Design. Englewood Cliffs, NJ: Prentice-Hall. Eddy DM, Nugent FW, Eddy JF, Coller J, Gilbertsen V, Gottlieb LS, Rice R, Sherlock P, Winawer S. 1987. Screening for colorectal cancer in a high-risk population. Results of a mathematical model. Gastroenterol 92(3):682–692. Edwards BK, Howe HL, Ries LAG, Thun MJ, Rosenberg HM, Yancik R, Wingo PA, Jemal A, Feigal EG. 2002. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer 94(10):2766–2792. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. 2000. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 84(15):1954–1961. Glick S, Wagner JL, Johnson CD. 1998. Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer. AJR AM JRoentgeno 170(3):629–636. Gohagan JK, Prorok PC, Kramer BS, Hayes RB, Cornett JE. 1995. The prostate, lung, colorectal, and ovarian cancer screening trial of the National Cancer Institute. Cancer 75(7 Suppl.): 1869–1873. Gold MR, Siegel J, Russell L, Weinstein, M. 1996. Cost-Effectiveness in Health and Medicine New York: Oxford University Press. Herdman R, Norton L (eds). 2005. Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis. National Cancer Policy Board, Institute of Medicine. Washington DC: The National Acadamies Press. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. 2003. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med 139(12):959–965. Jorgensen OD, Kronborg O, Fenger C. 2002. A randomised study of screening for colorectal cancer using faecal occult blood testing: Results after 13 years and seven biennial screening rounds. Gu. 50(1):29–32. Joseph AM, Crowson TW, Rich EC. 1988. Cost effectiveness of HemoQuant versus Hemoccult for colorectal cancer screening. J Gen Intern Med 3(2):132–138. Khandker RK, Dulski JD, Kilpatrick JB, Ellis RP, Mitchell JB, Baine WB. 2000. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care 16(3):799–810.

OCR for page 31
Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary Kowalczyk L. 2004, August 1. Colonoscopies tax health industry. The Boston Globe A-1. Ladabaum U, Song K, Fendrick AM. 2004. Colorectal neoplasia screening with virtual colonoscopy: When, at what cost, and with what national impact? Clinical Gastroenterology & Hepatology 2(7):554–563. Lieberman DA. 1995. Cost-effectiveness model for colon cancer screening. Gastroenterol 109(6): 1781–90. Lieberman DA, Prindiville S, Weiss DG, Willett W. 2003. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 290(22):2959–2967. Lieberman DA, Prindiville S, Weiss DG, Willett W, Imperiale T. 2004. Risk factors for advanced colonic neoplasia: From evidence to application. Evidence-Based Gastroenterology 5(3):86–87. Loeve F, Boer R, Van Oortmarssen GJ, Van Ballegooijen M, Habbema JDF. 1999. The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res 32(1):13–33. Loeve F, Brown ML, Boer R, Van Ballegooijen M, Van Oortmarssen GJ, Habbema JDF. 2000. Endoscopic colorectal cancer screening: A cost-saving analysis. J Natl Cancer Inst 92(7): 557–563. Mandel JS, Church TR, Ederer F, Bond JH. 1999. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91(5):434–437. Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. 2004. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med 141(4). Neilson AR, Whynes DK. 1995. Cost-effectiveness of screening for colorectal cancer: A simulation model. IMA J Math Appl Med Biol 12(3–4):355–367. Ness RM, Holmes AM, Klein R, Dittus R. 2000. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Am J Gastroenterol 95(7):1800–1811. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, Wong RK, Nugent PA, Mysliwiec PA, Schindler WR. 2003. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349(23):2191–2200. Pignone M, Saha S, Hoerger T, Mandelblatt J. 2002. Cost-effectiveness analyses of colorectal cancer screening: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 137(2):96–104. Ransohoff DF. 2004. Virtual colonoscopy: What it can do vs what it will do. JAMA 291(14): 1772–1774. Schoen RE, Pinsky PF, Weissfeld JL, Bresalier RS, Church T, Prorok P, Gohagan JK. 2003. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA 290(1):41–48. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. 2002. Effect of faecal occult blood screening on mortality from colorectal cancer: Results from a randomised controlled trial. Gut 50(6):840–844. Smith RA, Cokkinides V, Eyre HJ. 2004. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin 54(1):41–52. Song K, Fendrick AM, Ladabaum U. 2004. Fecal DNA testing compared with conventional colorectal cancer screening methods: A decision analysis. Gastroenterol 126(5):1270–1279. Sonnenberg A, Delco F. 2002. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med 162(2):163–168. Sonnenberg A, Delco F, Inadomi JM. 2000. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 133(8):573–584. Theuer CP, Wagner JL, Taylor TH, Brewster WR, Tran D, McLaren CE, Anton-Culver H. 2001. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterol 120(4):848–856. Trochim WM. 2004. The Research Methods Knowledge Base. 2nd ed. [online] http://www.socialresearchmethods.net/kb/index.htm. United States General Accounting Office. 2004. Coverage of Common Colorectal Cancer Screening Tests Is Common. Washington DC: United States General Accounting Office.

OCR for page 31
Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary U.S. Preventive Services Task Force. 2002. Screening for colorectal cancer: Recommendation and rationale. Ann Intern Med 137(2):132–141. Vijan S, Hwang EW, Hofer TP, Hayward RA. 2001. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 111(8):593–601. Wagner JL, Herdman RC, Wadhwa S. 1991. Cost effectiveness of colorectal cancer screening in the elderly. Ann Intern Med 115(10):807–817. Wagner J, Tunis S, Brown M, Ching A, Almeida R. 1996. Cost-Effectiveness of Colorectal Cancer Screening in Average-Risk Adults. In: Young G, Rosen P, Levin B (eds). Prevention and Early Detection of Colorectal Cancer. Philadelphia: Saunders. Pp. 321–356. Walker Jr B, Figgs LW, Zahm SH. 1995. Differences in cancer incidence, mortality, and survival between African Americans and whites. Environ Health Perspect 103(Suppl. 8):275–281. Whynes DK. 2004. Cost-effectiveness of screening for colorectal cancer: Evidence from the Nottingham faecal occult blood trial. J Med Screen 11(1):11–15. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C. 2003. Colorectal cancer screening and surveillance: Clinical guidelines and rationale: Update based on new evidence. Gastroenterol 124(2):544–560. Winawer SJ, Zauber AG, May Nah Ho, O’Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET, Lightdale CJ, Edelman M, Fleisher M. 1993. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 329(27):1977–1981.

OCR for page 31
Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary This page intentionally left blank.